Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings.
Kirchhoff, Timm
Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings. [electronic resource] - Rheumatology (Oxford, England) Apr 2011 - 756-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1462-0332
10.1093/rheumatology/keq398 doi
Adult
Aged
Antirheumatic Agents--economics
Arthritis, Rheumatoid--drug therapy
Cohort Studies
Cost Savings--statistics & numerical data
Cost of Illness
Cost-Benefit Analysis
Efficiency
Female
Germany--epidemiology
Health Care Costs--statistics & numerical data
Hospitalization--economics
Humans
Male
Middle Aged
Retrospective Studies
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors
Cost of illness in rheumatoid arthritis in Germany in 1997-98 and 2002: cost drivers and cost savings. [electronic resource] - Rheumatology (Oxford, England) Apr 2011 - 756-61 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1462-0332
10.1093/rheumatology/keq398 doi
Adult
Aged
Antirheumatic Agents--economics
Arthritis, Rheumatoid--drug therapy
Cohort Studies
Cost Savings--statistics & numerical data
Cost of Illness
Cost-Benefit Analysis
Efficiency
Female
Germany--epidemiology
Health Care Costs--statistics & numerical data
Hospitalization--economics
Humans
Male
Middle Aged
Retrospective Studies
Treatment Outcome
Tumor Necrosis Factor-alpha--antagonists & inhibitors